Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Federal Trade Commission
Teva
Express Scripts
Boehringer Ingelheim
Johnson and Johnson
Dow
Moodys
Cipla

Generated: January 16, 2019

DrugPatentWatch Database Preview

Sun Pharma Global Company Profile

« Back to Dashboard

Summary for Sun Pharma Global
International Patents:160
US Patents:8
Tradenames:72
Ingredients:71
NDAs:82
Patent Litigation for Sun Pharma Global: See patent lawsuits for Sun Pharma Global

Drugs and US Patents for Sun Pharma Global

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharma Global CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF cetirizine hydrochloride TABLET, CHEWABLE;ORAL 090142-004 Aug 30, 2011 OTC No No ➤ Sign Up ➤ Sign Up
Sun Pharma Global CINACALCET HYDROCHLORIDE cinacalcet hydrochloride TABLET;ORAL 207008-002 Oct 11, 2018 AB RX No No ➤ Sign Up ➤ Sign Up
Sun Pharma Global LEVOCETIRIZINE DIHYDROCHLORIDE levocetirizine dihydrochloride TABLET;ORAL 090362-001 Jan 31, 2013 AB RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for SUN PHARMA GLOBAL drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Tablets 125 mg ➤ Subscribe 2018-07-23

Supplementary Protection Certificates for Sun Pharma Global Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0012 France ➤ Sign Up PRODUCT NAME: IMATINIB MESILATE; NAT. REGISTRATION NO/DATE: EU/1/01/198/001 20011107; FIRST REGISTRATION: LI - IKS 55 807 20010621
C0009 Belgium ➤ Sign Up PRODUCT NAME: IRBESARTAN / HYDROCHLOROTHIAZIDE; REGISTRATION NO/DATE: EU/1/98/086/001 19981015
2015 00057 Denmark ➤ Sign Up PRODUCT NAME: SONIDEGIB ELLER ET FARMACEUTISK ACCEPTABELT SALT, HYDRAT ELLER SOLVAT DERAF, HERUNDER SONIDEGIBFOSFAT; REG. NO/DATE: EU/1/15/1030 20150818
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Covington
Citi
Chinese Patent Office
McKesson
Julphar
Chubb
US Army
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.